All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Equity

Grifols investor raises €170m in UBS-led sale

An institutional shareholder of Grifols, a Spanish pharmaceutical company, raised €168m through a sale of its stake on Thursday night as southern European equities continue to prove popular.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree